By Mill Chart
Last update: Apr 8, 2024
THE CIGNA GROUP (NYSE:CI) has caught the attention of our stock screener as a great value stock. NYSE:CI excels in profitability, solvency, and liquidity, all while being very reasonably priced. Let's delve into the details.
ChartMill assigns a proprietary Valuation Rating to each stock. The score is computed by evaluating various valuation aspects, like price to earnings and free cash flow, both absolutely as relative to the market and industry. NYSE:CI was assigned a score of 7 for valuation:
ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. NYSE:CI has earned a 6 out of 10:
Every stock is evaluated by ChartMill, receiving a Health Rating on a scale of 0 to 10. This assessment considers different health aspects, including liquidity and solvency, both in absolute terms and relative to industry peers. NYSE:CI has achieved a 5 out of 10:
ChartMill assigns a proprietary Growth Rating to each stock. The score is computed by evaluating various growth aspects, like EPS and revenue growth. We take into account the history as well as the estimated future numbers. NYSE:CI was assigned a score of 7 for growth:
More Decent Value stocks can be found in our Decent Value screener.
Check the latest full fundamental report of CI for a complete fundamental analysis.
This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
THE CIGNA GROUP
NYSE:CI (4/29/2024, 4:05:00 PM)
After market: 356.44 0 (0%)356.44
+1.97 (+0.56%)
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Besides Wall Street's top -and-bottom-line estimates for Cigna (CI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Don't overlook THE CIGNA GROUP (NYSE:CI)—a stock with solid growth prospects and a reasonable valuation.
/PRNewswire/ -- Many American children struggling with mental health challenges do not receive optimal care, and it's exacerbating the damaging ripple effect...
/PRNewswire/ -- In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health...
Cigna (CI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
/PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.40 per share of its common stock, payable on June 20,...
Between an aging population and increased government spending, investors should consider these three healthcare stocks to buy now.
/PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Brian Evanko, executive vice president and chief financial officer, will...
These are strong buy stocks within the healthcare industry that investors should watch in 2024 due to their strong returns.
Cigna Group could resume its abandoned pursuit of Humana Inc. after the stock prices have moved to the point where a deal makes financial sense, according to Jefferies.